These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 28336528)
1. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528 [TBL] [Abstract][Full Text] [Related]
2. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401 [TBL] [Abstract][Full Text] [Related]
3. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. Chen K; Febbraio M; Li W; Silverstein RL Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330 [TBL] [Abstract][Full Text] [Related]
4. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879 [TBL] [Abstract][Full Text] [Related]
5. TLR2 Plays a Key Role in Platelet Hyperreactivity and Accelerated Thrombosis Associated With Hyperlipidemia. Biswas S; Zimman A; Gao D; Byzova TV; Podrez EA Circ Res; 2017 Sep; 121(8):951-962. PubMed ID: 28775078 [TBL] [Abstract][Full Text] [Related]
6. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Podrez EA; Byzova TV; Febbraio M; Salomon RG; Ma Y; Valiyaveettil M; Poliakov E; Sun M; Finton PJ; Curtis BR; Chen J; Zhang R; Silverstein RL; Hazen SL Nat Med; 2007 Sep; 13(9):1086-95. PubMed ID: 17721545 [TBL] [Abstract][Full Text] [Related]
7. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia. Yang M; Li W; Harberg C; Chen W; Yue H; Ferreira RB; Wynia-Smith SL; Carroll KS; Zielonka J; Flaumenhaft R; Silverstein RL; Smith BC Blood Adv; 2020 Sep; 4(18):4494-4507. PubMed ID: 32946569 [TBL] [Abstract][Full Text] [Related]
8. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein. Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539 [TBL] [Abstract][Full Text] [Related]
9. CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function. Yang M; Silverstein RL Curr Opin Hematol; 2019 Sep; 26(5):357-365. PubMed ID: 31261174 [TBL] [Abstract][Full Text] [Related]
10. Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A. Berger M; Raslan Z; Aburima A; Magwenzi S; Wraith KS; Spurgeon BEJ; Hindle MS; Law R; Febbraio M; Naseem KM Haematologica; 2020 Mar; 105(3):808-819. PubMed ID: 31289200 [TBL] [Abstract][Full Text] [Related]
11. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36. Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222 [TBL] [Abstract][Full Text] [Related]
12. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940 [TBL] [Abstract][Full Text] [Related]
14. Scavenger receptor function of mouse Fcγ receptor III contributes to progression of atherosclerosis in apolipoprotein E hyperlipidemic mice. Zhu X; Ng HP; Lai YC; Craigo JK; Nagilla PS; Raghani P; Nagarajan S J Immunol; 2014 Sep; 193(5):2483-95. PubMed ID: 25038257 [TBL] [Abstract][Full Text] [Related]
16. Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis. Panigrahi S; Ma Y; Hong L; Gao D; West XZ; Salomon RG; Byzova TV; Podrez EA Circ Res; 2013 Jan; 112(1):103-12. PubMed ID: 23071157 [TBL] [Abstract][Full Text] [Related]
17. Differential Roles of the NADPH-Oxidase 1 and 2 in Platelet Activation and Thrombosis. Delaney MK; Kim K; Estevez B; Xu Z; Stojanovic-Terpo A; Shen B; Ushio-Fukai M; Cho J; Du X Arterioscler Thromb Vasc Biol; 2016 May; 36(5):846-54. PubMed ID: 26988594 [TBL] [Abstract][Full Text] [Related]
18. Regulation of platelet function by class B scavenger receptors in hyperlipidemia. Zimman A; Podrez EA Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2350-6. PubMed ID: 21071700 [TBL] [Abstract][Full Text] [Related]